Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects
NCT04438720Phase 1Unknown
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of nifedipine GITS in hypertension (HTN) (2 arms). Primary endpoints: Peak Plasma Concentration at 60 days, Area under the plasma concentration versus time curve from time zero to time t at 60 days and 1 more. Status: unknown.
02
Drugs
nifedipine GITS
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04438720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438720.